Pfizer Inc. is an American pharmaceutical company that made international headlines in 2020 for developing a COVID-19 mRNA vaccine that would reach the world.
Founded by German immigrants and headquartered in New York, Pfizer produces and also develops a variety of medicines. Pfizer's CEO is Albert Bourla, a Sephardic Jew.
On December 27, 2020, thousands of Pfizer vaccines arrived in Israel, kicking off the country's vaccination campaign.
Pfizer announced that there would be shortages of Bicillin L-A last month. Bicillin L-A is a long-acting injectable antibiotic that is also known as penicillin G benzathine.
The company's shares fell 3.5% in volatile premarket trading on Monday as Pfizer said it would stop developing its therapy lotiglipron.
Supply of the drug, Bicillin L-A, is expected to be exhausted by the end of this quarter, the company said in a letter to the US health regulator dated Monday.
The COVID products drove Pfizer's revenue to record levels, topping $100 billion in 2022 and $80 billion in 2021.
Every day, there are 40,000 migraine attacks in Israel. This new Pfizer treatment could help
The lawsuit by Arbutus and Genevant says Pfizer/BioNTech engaged in licensing discussions for the technology but they did not "result in a settlement."
Pfizer’s COVID-19 vaccine was the first shot approved by the US Food & Drug Administration (FDA) for Emergency Use, and Israel was the first country to mass vaccinate its population.
The multi-institution study, published in the peer-reviewed academic journal Current Biology, sheds light on the link between sleep duration and antibody response.
The World Health Organization reported that as many as 5 million people suffer from severe cases of influenza each year.
Israeli scientists announce 100% effectiveness of mRNA vaccine against Black Plague-causing bacteria in preclinical trial performed on mice.
JPOST Digital Library
